• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿发作期间补体、凝血、纤维蛋白溶解和激肽释放酶-激肽系统的激活。

Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.

作者信息

Nielsen E W, Johansen H T, Høgåsen K, Wuillemin W, Hack C E, Mollnes T E

机构信息

Department of Anaesthesiology, Nordland Central Hospital, Bodø, Norway.

出版信息

Scand J Immunol. 1996 Aug;44(2):185-92. doi: 10.1046/j.1365-3083.1996.d01-298.x.

DOI:10.1046/j.1365-3083.1996.d01-298.x
PMID:8711433
Abstract

Five patients with hereditary angioedema (HAE) were studied during attacks and remission as were healthy controls. The high levels of C1/C1-INH complexes, low C4 and high ratio C4 activation products (C4bc)/C4 also differed significantly during remission compared to controls. During attacks C4bc/C4 increased (922-2007; P = 0.022, remission versus attacks, median values throughout), C2 and CH50 dropped (111-31%; P = 0.043 and 110-36%; P = 0.016, respectively), TCC (C5b-9) increased (0.88-1.23 AU/ml; P = 0.028). Cleavage of HK increased to be almost complete during attacks (20-90%; P = 0.009). While factor XIa/serpin-complexes did not increase, a more than twofold rise in thrombin/antithrombin-complexes (0.20-0.50 microgram/l; P = 0.009) and in plasmin/alpha-2-antiplasmin-complexes (7.3-17 nmol/l; P = 0.028) was observed. For the first time cascade activation in HAE was studied simultaneously, and corroborates that attacks lead to activation of the kallikrein-kinin system, fibrinolysis and early part of the classical complement pathway. In addition, the authors present novel data of terminal complement and coagulation activation, the latter apparently not via FXIa.

摘要

对5例遗传性血管性水肿(HAE)患者在发作期和缓解期进行了研究,并与健康对照者进行了对比。与对照组相比,缓解期时C1/C1-INH复合物水平较高、C4水平较低以及C4激活产物(C4bc)/C4比值较高,这些差异也非常显著。发作期时,C4bc/C4升高(922 - 2007;缓解期与发作期相比,P = 0.022,均为中位数),C2和CH50下降(分别为111 - 31%;P = 0.043和110 - 36%;P = 0.016),末端补体复合物(TCC,C5b - 9)升高(0.88 - 1.23 AU/ml;P = 0.028)。激肽释放酶原(HK)的裂解在发作期增加至几乎完全裂解(20 - 90%;P = 0.009)。虽然因子XIa/丝氨酸蛋白酶抑制剂复合物未增加,但观察到凝血酶/抗凝血酶复合物(0.20 - 0.50微克/升;P = 0.009)和纤溶酶/α2 - 抗纤溶酶复合物(7.3 - 17纳摩尔/升;P = 0.028)增加了两倍多。首次同时研究了HAE中的级联激活情况,证实发作会导致激肽释放酶 - 激肽系统、纤维蛋白溶解以及经典补体途径早期部分的激活。此外,作者还展示了末端补体和凝血激活的新数据,后者显然不是通过因子XIa激活的。

相似文献

1
Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.遗传性血管性水肿发作期间补体、凝血、纤维蛋白溶解和激肽释放酶-激肽系统的激活。
Scand J Immunol. 1996 Aug;44(2):185-92. doi: 10.1046/j.1365-3083.1996.d01-298.x.
2
C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients.
Scand J Immunol. 1995 Dec;42(6):679-85. doi: 10.1111/j.1365-3083.1995.tb03711.x.
3
Activation of the coagulation cascade in C1-inhibitor deficiencies.C1抑制剂缺乏时凝血级联反应的激活。
Blood. 1997 May 1;89(9):3213-8.
4
The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.内源性凝血-激肽途径、补体级联反应、血浆肾素-血管紧张素系统及其相互关系。
Crit Rev Immunol. 1981 Sep;3(1):75-93.
5
Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).遗传性血管性水肿(HAE)中的补体、凝血和纤维蛋白溶解参数
Clin Exp Immunol. 1982 Sep;49(3):618-22.
6
C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.C1抑制剂聚合物激活依赖于FXII的激肽释放酶-激肽系统:对遗传性血管性水肿作用的启示。
Biochim Biophys Acta. 2015 Jun;1850(6):1336-42. doi: 10.1016/j.bbagen.2015.03.005. Epub 2015 Mar 20.
7
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.遗传性血管性水肿中的前激肽释放酶激活和高分子量激肽原消耗
N Engl J Med. 1983 May 5;308(18):1050-3. doi: 10.1056/NEJM198305053081802.
8
Generation of plasmin during acute attacks of hereditary angioedema.遗传性血管性水肿急性发作期间纤溶酶的产生。
J Lab Clin Med. 1993 Jan;121(1):38-43.
9
Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.由于凝血因子XII基因突变Thr309Lys导致的遗传性血管性水肿中的激肽释放酶-激肽系统与纤维蛋白溶解
Blood Coagul Fibrinolysis. 2009 Jul;20(5):325-32. doi: 10.1097/MBC.0b013e32832811f8.
10
Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.通过反义寡核苷酸抑制血浆激肽释放酶和凝血因子 12 抑制血管通透性。
Nucleic Acid Ther. 2013 Jun;23(3):175-87. doi: 10.1089/nat.2013.0417. Epub 2013 Apr 12.

引用本文的文献

1
Th2 predominance and decreased NK cells in patients with hereditary angioedema.遗传性血管性水肿患者中Th2优势及自然杀伤细胞减少
Front Immunol. 2025 May 14;16:1536128. doi: 10.3389/fimmu.2025.1536128. eCollection 2025.
2
Increased thromboinflammatory load in hereditary angioedema.遗传性血管性水肿患者血栓炎症负荷增加。
Clin Exp Immunol. 2023 Dec 12;214(2):170-181. doi: 10.1093/cei/uxad091.
3
A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1.遗传性血管性水肿中喉部发作的一种新的致病因素?蛋白酶激活受体1的作用。
Allergy Asthma Clin Immunol. 2022 Jul 4;18(1):60. doi: 10.1186/s13223-022-00699-7.
4
Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.肾素-血管紧张素、补体和激肽释放酶-激肽系统在炎症中的相互作用。
Nat Rev Immunol. 2022 Jul;22(7):411-428. doi: 10.1038/s41577-021-00634-8. Epub 2021 Nov 10.
5
Biomarkers in Hereditary Angioedema.遗传性血管性水肿的生物标志物。
Clin Rev Allergy Immunol. 2021 Jun;60(3):404-415. doi: 10.1007/s12016-021-08845-6. Epub 2021 Feb 9.
6
Does hereditary angioedema make COVID-19 worse?遗传性血管性水肿会使新冠病毒疾病病情加重吗?
World Allergy Organ J. 2020 Sep;13(9):100454. doi: 10.1016/j.waojou.2020.100454. Epub 2020 Aug 10.
7
Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.健康人群和遗传性血管性水肿患者中 C1 抑制剂/血浆丝氨酸蛋白酶复合物的模式。
Front Immunol. 2020 May 5;11:794. doi: 10.3389/fimmu.2020.00794. eCollection 2020.
8
Plasminflammation-An Emerging Pathway to Bradykinin Production.纤溶炎症——缓激肽产生的新途径。
Front Immunol. 2019 Aug 27;10:2046. doi: 10.3389/fimmu.2019.02046. eCollection 2019.
9
The Search for Biomarkers in Hereditary Angioedema.遗传性血管性水肿生物标志物的研究
Front Med (Lausanne). 2017 Nov 22;4:206. doi: 10.3389/fmed.2017.00206. eCollection 2017.
10
The Story of Angioedema: from Quincke to Bradykinin.血管性水肿的故事:从昆克到缓激肽。
Clin Rev Allergy Immunol. 2016 Oct;51(2):121-39. doi: 10.1007/s12016-016-8553-8.